1. The Lancet Global Health
Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis 
Sanjay Basu, MD, Ryan G Wagner, PhD, Ronel Sewpaul, MS, Priscilla Reddy, PhD, Prof Justine Davies, MD 
The Lancet Global Health 
DOI: /S X(18)
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

2. Figure 1 Modelling approach
DALYs=disability-adjusted life-years. RECODe=risk equations for complications of type 2 diabetes. SANHANES=South African National Health and Nutrition Examination Survey.
The Lancet Global Health DOI: ( /S X(18) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

3. Figure 2
Alternative guidelines for management of elevated blood pressure, dyslipidaemia, and type 2 diabetes for South African providers
The management flow is shown according to the WHO PEN (A) and SA PC 101 (B) guidelines. ACE=angiotensin-converting enzyme. SA PC 101=South Africa's Primary Care 101. PEN=package of essential non-communicable disease interventions.
The Lancet Global Health DOI: ( /S X(18) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

4. Figure 3
DALYs averted from treatment according to different guidelines of elevated blood pressure, dyslipidaemia, and type 2 diabetes for the South African population, by sex, race and ethnicity, and socioeconomic status
The figure shows DALYs averted by treatment according to the WHO PEN and SA PC 101 guidelines. DALY=disability-adjusted life-year. PEN=package of essential non-communicable disease interventions. SA PC 101=South Africa's Primary Care 101.
The Lancet Global Health DOI: ( /S X(18) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions